{"raw_mentions": "When being detected, 10pM or less KD is carried with reference to Il-1R1."}
{"final_json": [{"molecule_name": null, "protein_target_name": "Il-1R1", "binding_metric": "KD", "value": "<=10", "unit": "pM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nBinding members of the present invention, which generally have, is used for people IL-1R1 (K<sub>D</sub>) compatibility be less than about 1nM, in some embodiments, the K having<sub>D</sub>Less than about 100pM, in other embodiments, the K having<sub>D</sub>Less than 50pM, in other embodiments, the K having<sub>D</sub>Less than 25pM, in other embodiments, the K having<sub>D</sub>Less than 10pM, in other embodiments, the K having<sub>D</sub>Less than 5pM, in other embodiments, the K having<sub>D</sub>Less than 3pM, in other embodiments, the K having<sub>D</sub>Less than 1pM.\nIn an embodiment of the invention, binding members of the present invention are to be specifically used for as used KinExA<sup>TM</sup>The 300pM or lower K of methodology measurement<sub>D</sub>IL-1R.Selectively 200pM or lower, 100pM or lower, 50pM or lower, 20pM or lower or 10pM or lower, 5pM or lower, 3pM or lower, 1pM or lower."}
{"final_json": [{"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "<1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "<100", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "<50", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "<25", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "<10", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "<5", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "<3", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "<1", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "300 or lower", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "200 or lower", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "100 or lower", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "50 or lower", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "20 or lower", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "10 or lower", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "5 or lower", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "3 or lower", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "IL-1R1", "binding_metric": "Kd", "value": "1 or lower", "unit": "pM"}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, IDs, or identifiers along with bioactivity metrics (IC50, Ki, Kd, EC50) and their corresponding numeric values with units."}
{"raw_mentions": "When dissociation constant be\u22641 \u03bcM, preferably\u2264100nM and most preferably\u226410nM when, antibody is considered as specifically combining antigen."}
{"final_json": [{"molecule_name": "antibody", "protein_target_name": "antigen", "binding_metric": "Kd", "value": "\u226410nM", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": "antigen", "binding_metric": "Kd", "value": "\u2264100nM", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": "antigen", "binding_metric": "Kd", "value": "\u22641 \u03bcM", "unit": "\u03bcM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nUsing the titration of scFv concentration with set up analysis in by IC<sub>50</sub>\nThen 2nM people HIS IL1RFc (when inside uses HIS IL1 \u03b2) or 8nM HIS IL1RFc (when using Alexis source IL1 \u03b2) are next added to 20 \u03bc l volume.\nPlus 2nM people HIS IL 1RFc are to 20 \u03bc l volumes then.\nFollowed by 5 \u03bc l 40nM FLAG IL-1 \u03b2 (internal Escherichia coli are expressed).\nFollowed by 5 \u03bc l 40nM be marked with XL665 (CIS Bio international 61FG2XLB) anti-FLAG IgG, 5 \u03bc l 3.2nM is marked with the Anti-Human Fc IgG of cryptate (CIS Bio international 61HFCKLB)."}
{"final_json": [{"molecule_name": "HIS IL1RFc", "protein_target_name": "IL1 \u03b2", "binding_metric": null, "value": "2nM", "unit": "nM"}, {"molecule_name": "HIS IL1RFc", "protein_target_name": "IL1 \u03b2", "binding_metric": null, "value": "8nM", "unit": "nM"}, {"molecule_name": "HIS IL 1RFc", "protein_target_name": null, "binding_metric": null, "value": "2nM", "unit": "nM"}, {"molecule_name": "FLAG IL-1 \u03b2", "protein_target_name": null, "binding_metric": null, "value": "40nM", "unit": "nM"}, {"molecule_name": "XL665 anti-FLAG IgG", "protein_target_name": null, "binding_metric": null, "value": "40nM", "unit": "nM"}, {"molecule_name": "Anti-Human Fc IgG of cryptate", "protein_target_name": null, "binding_metric": null, "value": "3.2nM", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe ligand binding assays for more than are carried out in analysis buffer.The inhibitor of 5 \u03bc l titration is added into 384 hole low volume analysis plates (Costar 3676).Then the HIS IL1RFc of 0.4nM cryptate mark are next added.\nFollowing 5 \u03bc l 40nM is marked with XL665 (CIS Bio international 61FG2XLB) anti-FLAG IgG immediately.\nThe 25 \u03bc l biotinylated people HIS IL 1RFc of 1.4nM are added to analysis plates.\nUsing four parameter logistic equations (equation 3) are by curve matching and use GraphPad Prism softwares to determine IC<sub>50</sub>Value.\nDuring lower addition biotinylation people HIS IL1RFc, the concentration of significant signal can be provided.\nStart under about 400 times of concentration of value\uff1aMachin (Macaca fascicularis) HIS IL 1RFc (internal HEK EBNA are expressed, as described below), rat HISIL 1RFc (internal HEK EBNA are expressed), recombined human IL1sRI (R\uff06D system 269-1R/CF), people IL-1R6/IL-1R rp2/Fc (R\uff06D system 872-RP), recombined human IL-18R \u03b1 (IL-1R5)/Fc (R\uff06D system 816-LR), recombined human IL-1R4 (ST2)/Fc (R\uff06D system 523-ST)."}
{"final_json": [{"molecule_name": "HIS IL1RFc", "protein_target_name": null, "binding_metric": null, "value": "0.4nM", "unit": "nM"}, {"molecule_name": "XL665 (CIS Bio international 61FG2XLB) anti-FLAG IgG", "protein_target_name": null, "binding_metric": null, "value": "40nM", "unit": "nM"}, {"molecule_name": "biotinylated people HIS IL 1RFc", "protein_target_name": null, "binding_metric": null, "value": "1.4nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": "Machin (Macaca fascicularis) HIS IL 1RFc", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "rat HISIL 1RFc", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "recombined human IL1sRI (R\uff06D system 269-1R/CF)", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "people IL-1R6/IL-1R rp2/Fc (R\uff06D system 872-RP)", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "recombined human IL-18R \u03b1 (IL-1R5)/Fc (R\uff06D system 816-LR)", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "recombined human IL-1R4 (ST2)/Fc (R\uff06D system 523-ST)", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nAntibody 6FAb has a KD of 2.5pM for people IL1-R1-Fc and 2.8pM for machins IL1-R1-Fc.\nAntibody 6IgG1TM has a KD of 3.05pM for people sIL-1R1.\nAMG108IgG2 has a KD of 4.12pM for people sIL-1R1.\nAntibody 6FAb  2.5pM  2.8pM\nAntibody 6IgG1TM  3.05pM \nAMG108IgG2  4.12pM"}
{"final_json": [{"molecule_name": "6FAb", "protein_target_name": "IL1-R1-Fc", "binding_metric": "KD", "value": "2.5pM", "unit": "pM"}, {"molecule_name": "6FAb", "protein_target_name": "IL1-R1-Fc", "binding_metric": "KD", "value": "2.8pM", "unit": "pM"}, {"molecule_name": "6IgG1TM", "protein_target_name": "sIL-1R1", "binding_metric": "KD", "value": "3.05pM", "unit": "pM"}, {"molecule_name": "AMG108IgG2", "protein_target_name": "sIL-1R1", "binding_metric": "KD", "value": "4.12pM", "unit": "pM"}, {"molecule_name": "6FAb", "protein_target_name": null, "binding_metric": null, "value": "2.5pM", "unit": "pM"}, {"molecule_name": "6FAb", "protein_target_name": null, "binding_metric": null, "value": "2.8pM", "unit": "pM"}, {"molecule_name": "6IgG1TM", "protein_target_name": null, "binding_metric": null, "value": "3.05pM", "unit": "pM"}, {"molecule_name": "AMG108IgG2", "protein_target_name": null, "binding_metric": null, "value": "4.12pM", "unit": "pM"}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n* The IC50 (nM) of chimeric IL-1R1 molecules and people IL-1R1 competition bindings to antibody.\n* Table 12\uff1aThe IC50 (nM) of chimeric IL-1R1 molecules and people IL-1R1 competition bindings to antibody.\n* Obtain perfect competition curve and calculate IC50 Value.\n* Full Domain swapping chimera by epitope mapping people IL1R1 (residue N123-V227) D2, all chimeras that mouse D2 domains containing IL-1R1 replace people D2IL-1R1 (MoIL-1R1, MoD1-D2HuD3IL1R1, MoD2HuD1HuD3IL1R1, MoD2-D3HuD1) can not completely inhibit people IL1R1, wherein those containing D2 people IL1R1 (HuIL, MoD3D1-D2) can completely and people IL-1R1 competes (table 12).\n* 2.5nM of 0.3nM biotin labelings 1 \u00d7 DBS\uff01(CisBio International Cat.No.611SAXLB), 0.1%BSA, 0.4M potassium fluoride.\n* analysis dilution series (from maximum 100nM to 0.0017nM).\n* The IC of (being shown in Table 12) people IL-1R1, mouse IL-1R1, chimeric molecule is calculated from suppression curve50Value.\n* IC similar to natural person IL-1R150The chimera of value further comprises epitope.\n* The combination of chimeric people/mouse IL-1R1 chimeras can make people's -1R1 epitope mappings of binding antibody, 0.1%BSA."}
{"final_json": [{"molecule_name": "chimeric IL-1R1 molecules", "protein_target_name": "IL-1R1", "binding_metric": "IC50", "value": null, "unit": "nM"}, {"molecule_name": "chimeric IL-1R1 molecules", "protein_target_name": "IL-1R1", "binding_metric": "IC50", "value": null, "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": "people IL1R1 (residue N123-V227) D2", "protein_target_name": "IL-1R1", "binding_metric": null, "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "0.3nM", "unit": null}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "100nM", "unit": "nM"}, {"molecule_name": "chimeric molecule", "protein_target_name": "IL-1R1", "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": "chimera of value", "protein_target_name": "IL-1R1", "binding_metric": "IC", "value": null, "unit": null}, {"molecule_name": "chimeric people/mouse IL-1R1 chimeras", "protein_target_name": "IL-1R1", "binding_metric": null, "value": null, "unit": null}]}
